Note: Video captions are generated with the assistance of AI and may contain errors.
David Lally, MD, presented at the 2025 Retina Society meeting, discussing the ARCHER study (NCT04656561) of ANX007 for the treatment of age-related macular…
David Lally discusses the ARCHER trial and the optimistic outcomes fueling future research | Ophthalmology Times
